Wei Zhi Chen
Direttore Tecnico/Scientifico/R&S presso Genecast Group, Inc.
Profilo
Wei Zhi Chen is currently the Chief Scientific Officer at Genecast Biotechnology Co. Ltd.
and Genecast Group, Inc. She previously worked as the Director of Research & Development Operations at GENEWIZ, Inc., Chief Technology Officer at Sinogenomax Co. Ltd., Head of Projects at Beijing Kaizheng Biotech Development Co. Ltd., Head of Research & Development at Simcere Diagnostics Co. Ltd., Chief Scientific Officer at Jiangyin Countercurrent Technology Co. Ltd., and Vice President of Research & Development at Jiangsu Simcere Diagnostics Co. Ltd.
Ms. Chen earned her doctorate degree from Peking Union Medical College in 1996.
Posizioni attive di Wei Zhi Chen
| Società | Posizione | Inizio |
|---|---|---|
Genecast Group, Inc.
 Genecast Group, Inc. Medical/Nursing ServicesHealth Services Genecast Group, Inc. operates as an oncology molecular diagnostics and testing company. The company was founded by Bo Du on August 10, 2021 and is headquartered in Wuxi, China. | Direttore Tecnico/Scientifico/R&S | 04/03/2022 |
Genecast Biotechnology Co. Ltd.
 Genecast Biotechnology Co. Ltd. Hospital/Nursing ManagementHealth Services Genecast Biotechnology Co. Ltd. is a Chinese company that operates in the field of cancer diagnosis. The company is based in Beijing, China. It was founded in 2014 and the CEO is Bo Du. | Direttore Tecnico/Scientifico/R&S | 01/04/2018 |
Precedenti posizioni note di Wei Zhi Chen
| Società | Posizione | Fine |
|---|---|---|
| Jiangsu Simcere Diagnostics Co. Ltd. | Corporate Officer/Principal | 01/03/2018 |
GENEWIZ, Inc.
 GENEWIZ, Inc. Miscellaneous Commercial ServicesCommercial Services GENEWIZ, Inc. provides research and development genomics services. Its services include Sanger deoxyribonucleic acid (DNA) sequencing, gene synthesis, next generation sequencing, molecular genetics, cloning and mutagenesis, plasmid DNA preparation, and good laboratory practice (GLP)-compliant services. The company was founded by Amy Liao and Steve Sun in 1999 and is headquartered in South Plainfield, NJ. | Corporate Officer/Principal | 01/07/2017 |
| Jiangyin Countercurrent Technology Co. Ltd. | Direttore Tecnico/Scientifico/R&S | 01/09/2010 |
| Sinogenomax Co. Ltd. | Corporate Officer/Principal | 01/09/2007 |
Beijing Kaizheng Biotech Development Co. Ltd.
 Beijing Kaizheng Biotech Development Co. Ltd. Medical SpecialtiesHealth Technology Beijing Kaizheng Biotech Development Co. Ltd. is a private company that develops blood serum technology. The company is based in Beijing, China. | Corporate Officer/Principal | 01/06/2006 |
Formazione di Wei Zhi Chen
| Peking Union Medical College | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
| Sinogenomax Co. Ltd. | |
Beijing Kaizheng Biotech Development Co. Ltd.
Beijing Kaizheng Biotech Development Co. Ltd. Medical SpecialtiesHealth Technology Beijing Kaizheng Biotech Development Co. Ltd. is a private company that develops blood serum technology. The company is based in Beijing, China. | Health Technology |
Genecast Biotechnology Co. Ltd.
Genecast Biotechnology Co. Ltd. Hospital/Nursing ManagementHealth Services Genecast Biotechnology Co. Ltd. is a Chinese company that operates in the field of cancer diagnosis. The company is based in Beijing, China. It was founded in 2014 and the CEO is Bo Du. | Health Services |
Genecast Group, Inc.
Genecast Group, Inc. Medical/Nursing ServicesHealth Services Genecast Group, Inc. operates as an oncology molecular diagnostics and testing company. The company was founded by Bo Du on August 10, 2021 and is headquartered in Wuxi, China. | Health Services |
| Simcere Diagnostics Co. Ltd. | |
| Jiangyin Countercurrent Technology Co. Ltd. | |
| Jiangsu Simcere Diagnostics Co. Ltd. | |
GENEWIZ, Inc.
GENEWIZ, Inc. Miscellaneous Commercial ServicesCommercial Services GENEWIZ, Inc. provides research and development genomics services. Its services include Sanger deoxyribonucleic acid (DNA) sequencing, gene synthesis, next generation sequencing, molecular genetics, cloning and mutagenesis, plasmid DNA preparation, and good laboratory practice (GLP)-compliant services. The company was founded by Amy Liao and Steve Sun in 1999 and is headquartered in South Plainfield, NJ. | Commercial Services |
- Borsa valori
- Insiders
- Wei Zhi Chen
